立体定向消融放疗治疗I期非小细胞肺癌患者的长期疗效令人鼓舞。 - Suppr

Suppr

超能文献

Encouraging long-term outcomes reported in patients with stage I non-small cell lung cancer treated with stereotactic ablative radiotherapy.

作者信息

Barton Mary Kay

出版信息

CA Cancer J Clin. 2017 Sep;67(5):349-350. doi: 10.3322/caac.21375. Epub 2017 Jul 11.

DOI:10.3322/caac.21375

PMID:28697271

Abstract

摘要

相似文献

Encouraging long-term outcomes reported in patients with stage I non-small cell lung cancer treated with stereotactic ablative radiotherapy.立体定向消融放疗治疗I期非小细胞肺癌患者的长期疗效令人鼓舞。

CA Cancer J Clin. 2017 Sep;67(5):349-350. doi: 10.3322/caac.21375. Epub 2017 Jul 11.

7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.I期非小细胞肺癌患者立体定向消融放疗后的7年随访：一项2期临床试验的结果

Cancer. 2017 Aug 15;123(16):3031-3039. doi: 10.1002/cncr.30693. Epub 2017 Mar 27.

Stereotactic ablative radiation therapy for primary lung tumors.立体定向消融放疗治疗原发性肺部肿瘤。

Cancer J. 2011 Jan-Feb;17(1):28-32. doi: 10.1097/PPO.0b013e31820a7f80.

Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.肺癌的立体定向体部放射治疗与消融治疗

Surg Oncol Clin N Am. 2016 Jul;25(3):553-66. doi: 10.1016/j.soc.2016.02.008.

Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.I期非小细胞肺癌的立体定向体部放射治疗（立体定向消融放疗）——放射生物学、技术及临床结果的更新

Discov Med. 2010 May;9(48):411-7.

Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial.立体定向消融放疗或手术治疗ⅠA期非小细胞肺癌后的患者报告结局：ROSEL多中心随机试验结果

Radiother Oncol. 2015 Oct;117(1):44-8. doi: 10.1016/j.radonc.2015.08.011.

A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.放射肿瘤学家和胸外科医生对立体定向消融放疗治疗可手术肺癌作用的观点。

Semin Thorac Cardiovasc Surg. 2013 Spring;25(1):8-13. doi: 10.1053/j.semtcvs.2013.01.006.

Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes.立体定向消融放疗治疗无法手术的早期肺癌：早期结果。

Hong Kong Med J. 2012 Oct;18(5):412-8.

Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.I期肺癌健康患者的肺叶切除术与立体定向体部放疗对比

J Thorac Cardiovasc Surg. 2016 Jul;152(1):44-54.e9. doi: 10.1016/j.jtcvs.2016.03.060. Epub 2016 Apr 7.

Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer.明确射频消融术和立体定向消融放疗在高危早期非小细胞肺癌患者中的作用。

Cancer. 2016 Jan 15;122(2):322-3. doi: 10.1002/cncr.29698. Epub 2015 Sep 30.

引用本文的文献

Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation.知母皂苷 AIII 通过靶向和促进 HSP90 介导的 GPX4 泛素化和降解促进非小细胞肺癌铁死亡。

Int J Biol Sci. 2023 Feb 27;19(5):1471-1489. doi: 10.7150/ijbs.77979. eCollection 2023.

Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).泛素连接酶 E2T（UBE2T）的敲低通过靶向纤维连接蛋白 5（FBLN5）抑制肺腺癌进展。

Bioengineered. 2022 May;13(5):11867-11880. doi: 10.1080/21655979.2022.2060162.

High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.FHL2 高表达加剧了非小细胞肺癌（NSCLC）患者的预后不良和 NSCLC 细胞的恶性表型。

Int J Exp Pathol. 2022 Jun;103(3):90-101. doi: 10.1111/iep.12436. Epub 2022 Apr 2.

Recent Advances in Functional Carbon Quantum Dots for Antitumour.功能化碳量子点在抗肿瘤方面的最新进展。

Int J Nanomedicine. 2021 Oct 23;16:7195-7229. doi: 10.2147/IJN.S334012. eCollection 2021.

An Anti-Cancer Peptide LVTX-8 Inhibits the Proliferation and Migration of Lung Tumor Cells by Regulating Causal Genes' Expression in p53-Related Pathways.一种抗癌肽 LVTX-8 通过调节与 p53 相关通路中的关键基因表达来抑制肺癌肿瘤细胞的增殖和迁移。

Toxins (Basel). 2020 Jun 2;12(6):367. doi: 10.3390/toxins12060367.

The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer.非小细胞肺癌中异常lncRNA-miRNA-mRNA网络的构建与分析

J Thorac Dis. 2019 May;11(5):1772-1778. doi: 10.21037/jtd.2019.05.69.

UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.UBE2C 被 miR-548e-5p 直接靶向，增加了与非小细胞肺癌中 EMT 标志物蛋白锌指 E-box 结合同源框 1/2 相互作用的癌细胞的细胞生长和侵袭能力。

Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.

Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients.现代放疗进一步提高非小细胞肺癌患者生存率：对288,670例患者的分析

J Cancer. 2019 Jan 1;10(1):168-177. doi: 10.7150/jca.26600. eCollection 2019.

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.miR-495-UBE2C-ABCG2/ERCC1 轴通过下调顺铂耐药非小细胞肺癌细胞中的耐药基因逆转顺铂耐药性。

EBioMedicine. 2018 Sep;35:204-221. doi: 10.1016/j.ebiom.2018.08.001. Epub 2018 Aug 23.

AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.AFAP1-AS1：一种在人类癌症中发现的新型致癌长链非编码RNA。

Cell Prolif. 2018 Feb;51(1). doi: 10.1111/cpr.12397. Epub 2017 Oct 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验